Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
US9353100B2 · kind B2 · utility
0Cited by
67References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2012 |
| Grant date | May 31, 2016 |
| Priority date | — |
| Expiry date | Aug 18, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, and pharmaceutical compositions and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.